Stock 22UA BIONTECH SE
Add to a list
To use this feature you must be a member
Log inSign up

News BioNTech SE Xetra

Equities

22UA

US09075V1026

Real-time Estimate Tradegate
Other stock markets
 09:30:34 2024-05-21 EDT 		5-day change 1st Jan Change
84.3 EUR +0.84% Intraday chart for BioNTech SE -1.34% -11.12%
12:46pm Medigene, BioNTech Extend Cancer Immunotherapy Partnership MT
05-17 Sector Update: Health Care Stocks Mixed Late Afternoon MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Medigene, BioNTech Extend Cancer Immunotherapy Partnership
MT
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
GL
Sector Update: Health Care Stocks Mixed Late Afternoon
MT
Sector Update: Health Care Stocks Softer Friday Afternoon
MT
Sector Update: Health Care
MT
Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
MT
Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
MT
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program
MT
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot, FT reports
RE
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GL
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program
MT
Autolus Therapeutics' Q1 Loss Widens, Licensing Revenue Rises
MT
Evercore ISI Starts BioNTech With In Line Rating, $100 Price Target
MT
BioNTech : Corporate Presentation
PU
BIONTECH : UBS remains Neutral
ZD
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
MT
HC Wainwright Raises BioNTech SE Price Target to $113 From $107, Maintains Buy Rating
MT
BIONTECH : Deutsche Bank reaffirms its Neutral rating
ZD
TD Cowen Adjusts BioNTech Price Target to $98 From $95, Maintains Hold Rating
MT
BMO Capital Adjusts BioNTech Price Target to $122 From $123, Maintains Outperform Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BNTX Stock
  4. 22UA Stock
  5. News BioNTech SE
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW